Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kallikrein-14 (KLK14) is a serine protease belonging to the kallikrein subfamily. It exhibits both trypsin-like and chymotrypsin-like activity and is involved in various biological processes, including blood pressure regulation, epidermal desquamation, and potentially cancer progression. It is expressed in multiple tissues including breast, skin, prostate, and brain. KLK14 is implicated in prostate, breast, and ovarian cancers and may serve as a biomarker.
Serine-type endopeptidase; cleaves peptide bonds
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kallikrein-14 (KLK14).